Hiding from danger, not from fear: Lockdown as a risk factor of probable PTSD among civilians after Strasbourg Christmas market terror attack.

Exposure Hyperarousal Lockdown Mental health services use PTSD Terrorist attack

Journal

Journal of psychiatric research
ISSN: 1879-1379
Titre abrégé: J Psychiatr Res
Pays: England
ID NLM: 0376331

Informations de publication

Date de publication:
12 2021
Historique:
received: 04 07 2021
revised: 25 09 2021
accepted: 19 10 2021
pubmed: 29 10 2021
medline: 26 2 2022
entrez: 28 10 2021
Statut: ppublish

Résumé

On December 11, 2018, five people were killed and 11 injured during a terrorist attack on Strasbourg's Christmas market. As the attacker was on the run during the night, part of the population was locked down for several hours. Our study aimed at assessing factors associated with the development of PTSD and health services use among the victims. Four hundred and twelve victims were followed up from 6 to 11 months after the attacks through phone calls by psychologists. The presence of probable PTSD was assessed with the Trauma Screening Questionnaire. In addition, we evaluated the type and level of exposure, and health services use after the attacks. Two hundred and twelve participants completed the phone interview. The prevalence of probable PTSD was 26.4%. Being locked down during the attack and the level of exposure were associated with probable PTSD (OR = 2.32 [1.17-4.59], p = 0.016 and OR = 1.49 [1.10-2.03], p = 0.010 respectively). Lockdown was especially associated with symptoms suggesting adrenergic hyperactivation (startle at surprise, dreams about the event). General and mental health services use was frequent among our sample (83% consulted either their GP or a mental health professional), but people living alone tend to use these health services more infrequently than these living with others. Though necessary, measures taken to protect victims, such as lockdown, may foster PTSD. Victims of terror attacks having been subjected to lockdown may have experienced powerlessness, fostering prolonged stress and fear. These victims may benefit from mental health support over the following months.

Identifiants

pubmed: 34710662
pii: S0022-3956(21)00631-2
doi: 10.1016/j.jpsychires.2021.10.035
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

262-268

Informations de copyright

Copyright © 2021 Elsevier Ltd. All rights reserved.

Auteurs

Amaury C Mengin (AC)

Hôpitaux Universitaires de Strasbourg, Pôle de Psychiatrie, Santé Mentale et Addictologie, Strasbourg, 1 Place de L'Hôpital, 67091, Strasbourg, France; Centre Régional Du Psychotraumatisme Grand Est, Strasbourg, France; INSERM U1114 Neuropsychologie Cognitive et Physiopathologie de La Schizophrénie, Strasbourg, France. Electronic address: amaury.mengin@chru-strasbourg.fr.

Julie M Rolling (JM)

Centre Régional Du Psychotraumatisme Grand Est, Strasbourg, France; Department of Child and Adolescent Psychiatry, Strasbourg University Hospitals, Strasbourg, France; CNRS UPR 3212, Institute for Cellular and Integrative Neurosciences, Strasbourg, France.

Cédric Palacio (C)

Hôpitaux Universitaires de Strasbourg, Pôle de Psychiatrie, Santé Mentale et Addictologie, Strasbourg, 1 Place de L'Hôpital, 67091, Strasbourg, France; Centre Régional Du Psychotraumatisme Grand Est, Strasbourg, France; Cellule D'Urgence Médico-Psychologique 67, Strasbourg, France.

Dominique Mastelli (D)

Hôpitaux Universitaires de Strasbourg, Pôle de Psychiatrie, Santé Mentale et Addictologie, Strasbourg, 1 Place de L'Hôpital, 67091, Strasbourg, France; Centre Régional Du Psychotraumatisme Grand Est, Strasbourg, France; Cellule D'Urgence Médico-Psychologique 67, Strasbourg, France.

Fabrice Berna (F)

Hôpitaux Universitaires de Strasbourg, Pôle de Psychiatrie, Santé Mentale et Addictologie, Strasbourg, 1 Place de L'Hôpital, 67091, Strasbourg, France; INSERM U1114 Neuropsychologie Cognitive et Physiopathologie de La Schizophrénie, Strasbourg, France; Strasbourg University, Faculty of Medicine, Strasbourg, France; Fédération de Médecine Translationnelle de Strasbourg, Strasbourg, France.

Carmen M Schroder (CM)

Department of Child and Adolescent Psychiatry, Strasbourg University Hospitals, Strasbourg, France; CNRS UPR 3212, Institute for Cellular and Integrative Neurosciences, Strasbourg, France; Strasbourg University, Faculty of Medicine, Strasbourg, France; Fédération de Médecine Translationnelle de Strasbourg, Strasbourg, France.

Pierre Vidailhet (P)

Hôpitaux Universitaires de Strasbourg, Pôle de Psychiatrie, Santé Mentale et Addictologie, Strasbourg, 1 Place de L'Hôpital, 67091, Strasbourg, France; Centre Régional Du Psychotraumatisme Grand Est, Strasbourg, France; INSERM U1114 Neuropsychologie Cognitive et Physiopathologie de La Schizophrénie, Strasbourg, France; Cellule D'Urgence Médico-Psychologique 67, Strasbourg, France; Strasbourg University, Faculty of Medicine, Strasbourg, France; Fédération de Médecine Translationnelle de Strasbourg, Strasbourg, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH